PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Olsalazine sodium - Inflammatory bowel disease
PAD Profile : Olsalazine sodium - Inflammatory bowel disease Important
Keywords :
Ulcerative colitis, IBD
Important Information :
Licensed in mild ulcerative colitis
Traffic Light Status
Status 1 of 1.
Guidelines
The following guidelines are available for this indication.
Other Drugs
- Adalimumab
- Azathioprine
- Infliximab
- Mercaptopurine
- Ciclosporin
- Golimumab
- Vedolizumab
- Allopurinol
- Balsalazide sodium
- Prednisolone
- Budesonide
- Tofacitinib
- Methotrexate
- Mesalazine (Systemic)
- Filgotinib
- Sulfasalazine
- Upadacitinib
- Risankizumab
Other Indications
No indications returned.
Additional Documents
No additional documents returned.
Committee Recommendations
No committee recommendations returned.
Associated BNF Codes
01. Gastro-Intestinal System
01.05.01. Aminosalicylates